Cargando…
Immunological efficacy of pneumococcal vaccine strategies in HIV-infected adults: a randomized clinical trial
The aim of this study was to compare the immunologic response to a prime-boost immunization strategy combining the 13-valent conjugate pneumococcal vaccine (PCV13) with the 23-valent polysaccharide pneumococcal vaccine (PPSV23) versus the PPSV23 alone in HIV-infected adults. HIV-infected adults were...
Autores principales: | Sadlier, C., O’Dea, S., Bennett, K., Dunne, J., Conlon, N., Bergin, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007521/ https://www.ncbi.nlm.nih.gov/pubmed/27580688 http://dx.doi.org/10.1038/srep32076 |
Ejemplares similares
-
Reliability and validity of a new HIV-specific questionnaire with adults living with HIV in Canada and Ireland: the HIV Disability Questionnaire (HDQ)
por: O’Brien, Kelly K., et al.
Publicado: (2015) -
Vaccine strategies to reduce the burden of pneumococcal disease in HIV-infected adults in Africa.
por: Thindwa, Deus, et al.
Publicado: (2020) -
Safety, immunogenicity and efficacy of pneumococcal conjugate vaccine in HIV-infected individuals
por: Nunes, Marta C., et al.
Publicado: (2012) -
Single-Dose 13-Valent Conjugate Pneumococcal Vaccine in People Living With HIV – Immunological Response and Protection
por: Romaru, Juliette, et al.
Publicado: (2021) -
Risk factors for pneumococcal carriage in adults living with HIV on antiretroviral therapy in the infant pneumococcal vaccine era in Malawi
por: Thindwa, Deus, et al.
Publicado: (2022)